MCL coexpression mm9:308

Phase1 CAGE Peaks

	Short description
Mm9::chr10:28749875..28749924,+	p@chr10:28749875..28749924 +
Mm9::chr10:43243886..43243899,+	p2@ENSMUST00000057649
Mm9::chr12:24587988..24588001,+	p@chr12:24587988..24588001 +
Mm9::chr12:70223961..70223973,+	p@chr12:70223961..70223973 +
Mm9::chr13:118018159..118018169,+	p@chr13:118018159..118018169 +
Mm9::chr14:28023521..28023536,+	p@chr14:28023521..28023536 +
Mm9::chr15:81296769..81296795,+	p1@Gm9840 p1@Rbx1
Mm9::chr17:47547801..47547833,+	p@chr17:47547801..47547833 +
Mm9::chr18:38873969..38873988,+	p@chr18:38873969..38873988 +
Mm9::chr19:25107619..25107626,+	p@chr19:25107619..25107626 +
Mm9::chr19:28838027..28838030,-	p1@Gm6788
Mm9::chr1:13426571..13426575,+	p@chr1:13426571..13426575 +
Mm9::chr1:15057084..15057123,+	p@chr1:15057084..15057123 +
Mm9::chr2:150131486..150131493,+	p1@ENSMUST00000120921
Mm9::chr2:36244522..36244568,+	p1@ENSMUST00000121366
Mm9::chr2:52475255..52475266,+	p2@Bloc1s2 p2@Gm13540
Mm9::chr2:80479001..80479013,+	p3@Nup35
Mm9::chr4:116821517..116821519,+	p1@ENSMUST00000118674
Mm9::chr4:34432983..34433015,+	p2@ENSMUST00000117487
Mm9::chr7:144629334..144629355,+	p1@Gm12669
Mm9::chr7:3181067..3181081,+	p@chr7:3181067..3181081 +
Mm9::chr7:54087766..54087785,+	p2@Gm5331
Mm9::chr7:54087805..54087833,+	p1@Gm5331
Mm9::chr9:120293968..120293975,+	p1@ENSMUST00000118890
Mm9::chr9:48258428..48258437,+	p5@Gm5616 p5@LOC100045968 p5@LOC100505330 p5@Nhp2l1
Mm9::chrX:101543820..101543838,-	p1@ENSMUST00000120233

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0009055	electron carrier activity	0.0235749622765852
GO:0015035	protein disulfide oxidoreductase activity	0.030000362435492
GO:0006118	electron transport	0.030000362435492
GO:0031975	envelope	0.030000362435492
GO:0031967	organelle envelope	0.030000362435492
GO:0015036	disulfide oxidoreductase activity	0.030000362435492
GO:0006091	generation of precursor metabolites and energy	0.030000362435492
GO:0031090	organelle membrane	0.0382432531186327
GO:0045454	cell redox homeostasis	0.0382432531186327
GO:0016491	oxidoreductase activity	0.0382432531186327
GO:0008137	NADH dehydrogenase (ubiquinone) activity	0.0382432531186327
GO:0003954	NADH dehydrogenase activity	0.0382432531186327
GO:0050136	NADH dehydrogenase (quinone) activity	0.0382432531186327
GO:0051028	mRNA transport	0.0382432531186327
GO:0016655	oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor	0.0382432531186327
GO:0050658	RNA transport	0.0382432531186327
GO:0051236	establishment of RNA localization	0.0382432531186327
GO:0050657	nucleic acid transport	0.0382432531186327
GO:0006403	RNA localization	0.0382432531186327
GO:0005643	nuclear pore	0.0382432531186327
GO:0065002	intracellular protein transport across a membrane	0.0382432531186327
GO:0015931	nucleobase, nucleoside, nucleotide and nucleic acid transport	0.0382432531186327
GO:0046930	pore complex	0.0382432531186327
GO:0044453	nuclear membrane part	0.0395589900222561
GO:0031965	nuclear membrane	0.0395589900222561
GO:0016651	oxidoreductase activity, acting on NADH or NADPH	0.0398389700056067

Relative expression of the co-expression cluster over median <br>Analyst:

---

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}